Life Sciences & Biotechnology
Title : | Discovery of pyrimidines and intermediates as a human epidermal growth factor receptor (HER-2) and Apurinic/Apyrimidinic Endonuclease-1 (APE-1) inhibitors for breast cancer therapy: An synthetic approach |
Area of Research : | Life Sciences & Biotechnology, Medical Sciences |
Focus Area : | HER-2 and APE-1 inhibitors for breast cancer |
Principal Investigator : | Dr. Guru Basavaraja Swamy, Associate Professor, Acharya Institute of Technology, Bengaluru, Karnataka |
Contact info : | gurubasavaraj@acharya.ac.in |
Timeline Start Year : | 2017 |
Total Budget (INR): | 31,01,200 |
Details
Organizations involved